2150 ST. ELZEAR BLVD. WEST, QUEBEC, A8
Shareholder votes
News
Announces Increase in Shareholding by its Chairperson of the Board and Board Changes
Announces Second Quarter 2025 Results
To Acquire , Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
Announces the Appointment of Two New Members to Its Board of Directors
Appoints New Chief Accounting Officer
Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility
Q2
Q1
FY 2023
Q3
Tender Offer Statement by Third Party
Registration Statement for Securities to be Offered to Employees
Tender Offer Statement by Issuer
Certificate
Registration of Securities
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Statement of Changes in Beneficial Ownership
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Tender Offer Statement by Third Party
Specialized Disclosure Report